Oxford Bioscience Partners

Entry	Author	Date	Location
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines	Erin Kutz	05/18/12	Boston
Mitralign Lands $35,000,000 Series D Round	VentureDeal	05/16/12	Boston
SD Life Sciences News: Auspex, BrainCells, and J&J’s Startup Center	Bruce V. Bigelow	01/19/12	San Diego
Rib-X Pharma Files for IPO	Arlene Weintraub	11/28/11	Boston
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M	Luke Timmerman	08/19/11	Seattle
BrainCells Raises $1M, Moving Ahead Without CEO Schoeneck or CSO Barlow	Bruce V. Bigelow	08/03/11	San Diego
From Human Tissue Supplier to R&D Contractor to BioBank Builder, Asterand Seeks Its Future	Thomas Lee	03/16/11	Detroit
CardioFocus Finds $30.6M for Atrial Fibrillation Treatment	Ryan McBride	02/25/11	Boston
Report: Oxford Bioscience Has New Fund	Ryan McBride	01/11/11	Boston
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News	Erin Kutz	11/12/10	Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate	Ryan McBride	10/21/10	Boston
IBM Buys Unica, A123 Spinout Raises $10M, Zynga Acquires Conduit, & More Boston-Area Deals News	Erin Kutz	08/18/10	Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News	Rebecca Zacks	08/13/10	Boston
Trubion Pharmaceuticals Gets Acquired by Emergent BioSolutions for $97M Upfront	Luke Timmerman	08/12/10	Seattle
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs	Ryan McBride	08/11/10	Boston
Dicerna Pharmaceuticals Garners $25,000,000 Series B Funding	VentureDeal	08/11/10	Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News	Erin Kutz	07/02/10	Boston
$5M Debt Deal for Dicerna Pharma	Ryan McBride	06/30/10	Boston
SmartPill Garners $7,700,000 New Funding Round	VentureDeal	06/30/10	New York
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News	Erin Kutz	05/14/10	Boston
Doug Fambrough Reduces Role at Oxford Bioscience Partners, Becomes CEO of Portfolio Company Dicerna Pharma	Ryan McBride	05/06/10	Boston
The Vertex Alumni: Where Are They Now?	Luke Timmerman	04/29/10	Boston
For Biotech and Pharma, Emerging Markets Offer Great Potential and Require New Strategies, Panelists Say	Eva Regårdh	03/16/10	Boston
Luminus Devices Nabs $19M, Aveo Sets IPO Range, Thermo Fisher Scientific Reportedly Makes $6 B Move on Millipore, & More Boston-Area Deals News	Rebecca Zacks	02/24/10	Boston
Seahorse Bioscience Bags $5M	Howard Lovy	02/23/10	Boston
Seahorse Bioscience Lands $5,000,000 Series D Round	VentureDeal	02/23/10	Boston
Tragara Raises $5M	Bruce V. Bigelow	02/08/10	San Diego
Tragara Pharmaceuticals Garners $5,000,000 Series B Funding	VentureDeal	02/08/10	San Diego
Ironwood Pharma IPO Price Cut Could Be Only Half the Story	Ryan McBride	02/03/10	Boston
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry	Luke Timmerman	02/01/10	Boston
Page 1 of 3	next page »

Entry

Author

Date

Location

Promedior, Aveo, Ra, and More Boston Life Sciences Headlines

Erin Kutz

05/18/12

Boston

Mitralign Lands $35,000,000 Series D Round

VentureDeal

05/16/12

Boston